1. Home
  2. ELVN vs CAL Comparison

ELVN vs CAL Comparison

Compare ELVN & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

N/A

Current Price

$57.86

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Logo Caleres Inc.

CAL

Caleres Inc.

N/A

Current Price

$12.48

Market Cap

449.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ELVN
CAL
Founded
2016
1878
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
449.1M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ELVN
CAL
Price
$57.86
$12.48
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$43.40
$15.00
AVG Volume (30 Days)
1.0M
460.9K
Earning Date
05-11-2026
05-28-2026
Dividend Yield
N/A
2.13%
EPS Growth
3.17
N/A
EPS
N/A
0.42
Revenue
N/A
$85,513,000.00
Revenue This Year
N/A
$5.19
Revenue Next Year
N/A
$2.45
P/E Ratio
N/A
$29.86
Revenue Growth
N/A
0.46
52 Week Low
$14.79
$8.80
52 Week High
$62.32
$16.14

Technical Indicators

Market Signals
Indicator
ELVN
CAL
Relative Strength Index (RSI) 58.95 44.57
Support Level $56.69 $12.02
Resistance Level $62.32 $13.85
Average True Range (ATR) 1.92 0.51
MACD -0.28 -0.16
Stochastic Oscillator 57.25 10.05

Price Performance

Historical Comparison
ELVN
CAL

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

Share on Social Networks: